• USD/RUB USD/RUB 82.14
  • EUR/RUB EUR/RUB 92.19
  • CNY/RUB CNY/RUB 12.27
  • Bitcoin Bitcoin BTC $75747
  • Ethereum Ethereum ETH $2237
  • Ripple Ripple XRP $1.16
  • Solana Solana SOL $89.55
  • Cardano Cardano ADA $0.18
  • USD/RUB USD/RUB 82.14
  • EUR/RUB EUR/RUB 92.19
  • CNY/RUB CNY/RUB 12.27
  • Bitcoin Bitcoin BTC $75747
  • Ethereum Ethereum ETH $2237
  • Ripple Ripple XRP $1.16
  • Solana Solana SOL $89.55
  • Cardano Cardano ADA $0.18

A bioeconomical miracle: how India has increased the industry 16 times in 10 years

A bioeconomical miracle: how India has increased the industry 16 times in 10 years
Most Popular
04.11
China’s first Made in Belarus pavilion has opened in Heihe
04.11
September issue of the container transport study released
04.11
Distribution of declarations among electronic declaration centres has created customs value problems
04.11
AI law: requirements for business and the 1 March 2027 deadline
04.11
Two thirds of Far East–Europe container capacity has returned to Suez
04.11
Zhengzhou launched a direct freight train to Map Ta Phut in Thailand
India's bioeconomy has grown from $10 billion to $165 billion in 10 years. The country has become a leader in vaccine production and has reached 20% ethanol content in gasoline ahead of schedule.

India is making impressive strides in developing the bioeconomy, showing one of the fastest growth rates in the world over the past decade. According to the international agency IANS, the volume of this strategically important sector has increased more than sixteen times, from a modest $10 billion in 2014 to an impressive $165.7 billion in 2024.

Bioeconomics based on the use of renewable biological resources has become a key driver of Indian economic development. The current structure of the sector is characterized by the predominance of industrial production and the pharmaceutical industry, while agricultural technologies and scientific research occupy a slightly smaller but strategically important share.

India has achieved particular success in the pharmaceutical sector. Already in 2025, the country has consolidated its position as a world leader in the production of vaccines, significantly increasing both domestic production and export of medical products. This achievement is of particular importance in the context of the global need for affordable and high-quality biotechnological products.

One of the most significant breakthroughs was the energy program. India managed to reach the 20% ethanol content target in gasoline ahead of schedule, five years ahead of schedule. For comparison, in 2014 this figure was only 1.5%, which demonstrates tremendous progress in the field of renewable energy sources.

The ethanol production program has brought tangible benefits to Indian farmers. Over the years of the project, agricultural producers have received about $182.9 billion for the supply of raw materials for the production of biofuels. This significantly increased the profitability of the agricultural sector and contributed to the development of rural regions of the country.

The Indian government has no plans to stop there. An ambitious goal has already been set to bring the volume of the bioeconomy to $300 billion by 2030. This growth implies the further development of biotechnologies, the improvement of agricultural practices, the expansion of bio-production and the strengthening of positions in the healthcare sector.

India's success in developing the bioeconomy is becoming an important example for other emerging economies, demonstrating how sound government policies and investments in innovative biotechnologies can contribute to sustainable economic growth and improve the quality of life of the population.